Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

BLSH vs AMBQ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BLSH Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

BLSH Overall Winner 6-Pillar Tally: BLSH 4 – 2 AMBQ Matrix Metrics: BLSH 6 – 4 AMBQ

As of Nov 16, 2026, Bullish (BLSH) is the stronger overall head-to-head candidate over Ambiq Micro, Inc. (AMBQ) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). BLSH carries a Unified Composite Score of 51.9/100 (HOLD) at $20.22 (34.1x Forward P/E, -264.8% operating margin), whereas AMBQ carries 46.9/100 (HOLD) at $44.59 (N/M Forward P/E, -36.0% operating margin).

  • Growth vs. Quality Trade-Off: BLSH earns the overall head-to-head edge with a stronger Unified Composite Score (51.9/100 HOLD vs. AMBQ 46.9/100 HOLD) and 2.89β · 91% Vol risk profile, whereas AMBQ leads top-line expansion (+110.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: BLSH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 32.0); meanwhile AMBQ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 42.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BLSH vs AMBQ
BLSH NYSE Head-to-Head Winner
Bullish
Finance Services
$20.22
-10.09% 1D
Market Cap $3.5B
TTM Revenue $301M
Forward P/E 34.1x
Beta / 30D Vol 2.89β · 91% Vol
Unified Composite Score
51.9 / 100 HOLD
Tech 33.0 Fund 56.0 Flow 74.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.9%), weak momentum, RSI 32
RSI-14: 32.0 · SMA20: $24.94 · SMA50: $30.72
AMBQ NYSE
Ambiq Micro, Inc.
Semiconductors & Related Devices
$44.59
-6.05% 1D
Market Cap $1.2B
TTM Revenue $118M
Forward P/E N/M
Beta / 30D Vol 3.71β · 125% Vol
Unified Composite Score
46.9 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 65.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 42
RSI-14: 42.3 · SMA20: $47.52 · SMA50: $56.35

6-Pillar Scorecard Institutional Category Breakdown (BLSH 4 – 2 AMBQ)

Columns: Metric · BLSH · AMBQ
1. Valuation Multiples BLSH
Forward P/E 34.1x N/M
Trailing P/E 34.1x N/M
PEG Ratio N/M N/M
EV / Revenue 13.1x 7.3x
2. Growth & Scale BLSH
Revenue Growth (YoY) +68.8% +110.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $301M $118M
Market Cap $3.5B $1.2B
3. Profitability & Quality AMBQ
Gross Margin 100.0% 44.8%
Operating Margin -264.8% -36.0%
Net Profit Margin 0.0% -29.7%
Return on Equity (ROE) -57.1% -12.2%
4. Balance Sheet & Cash Flow BLSH
Cash Generation (TTM) $111M -$40M
Cash Flow Margin 37.0% -33.8%
Net Cash / Leverage $432M Net Debt (0.21x D/E) $359M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning BLSH
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 120.2% (15th %ile) 96.5% (27th %ile)
Put/Call OI Skew 0.71x (Call-Skewed) 2.14x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat AMBQ
OpEx & R&D Intensity N/A 80.8% of Rev ($95M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Infrastructure Operator Semiconductors Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BLSH (6) vs AMBQ (4)
Institutional Metric BLSH AMBQ Criterion Row Edge
Market Capitalization
Scale
$3.5B $1.2B Larger Scale BLSH
Trailing P/E Ratio
Valuation
34.1x N/M Lower Multiple BLSH
Forward P/E Ratio
Valuation
34.1x N/M Lower Multiple BLSH
Revenue Growth (YoY)
Growth
+68.8% +110.0% Higher Growth AMBQ
Operating Margin (TTM)
Profitability
-264.8% -36.0% Higher Margin AMBQ
Net Profit Margin
Profitability
0.0% -29.7% Higher Margin BLSH
Return on Equity (ROE)
Capital Efficiency
-57.1% -12.2% Higher ROE AMBQ
52-Week Range Position
Momentum
2% ($20–$49) 32% ($22–$92) Stronger Trend AMBQ
Beta / 30D Volatility
Risk Regime
2.89β · 91% Vol 3.71β · 125% Vol Lower Realized Risk BLSH
Unified Institutional Score
Composite Signal
51.9 / 100 (HOLD) 46.9 / 100 (HOLD) Higher Composite BLSH
Trailing 12M Revenue (USD)
Operating Scale
$301M $118M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 44.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 13.1x EV/Rev N/M PEG · 7.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$111M ($432M Net Debt (0.21x D/E)) -$40M ($359M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AMBQ +20.82 pp
BLSH: -31.43% · AMBQ: -10.61%
3M Horizon BLSH +11.36 pp
BLSH: -17.87% · AMBQ: -29.23%
6M Horizon AMBQ +5.64 pp
BLSH: -43.14% · AMBQ: -37.5%
1Y Horizon AMBQ +123.07 pp
BLSH: -50.71% · AMBQ: +72.36%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period BLSH Revenue AMBQ Revenue BLSH Op. Margin AMBQ Op. Margin Margin Leader
Q3 '25 $166.6B $70M 0.0% -55.3% BLSH
Q4 '25 $257.6B $80M 0.0% -57.7% BLSH
Q1 '26 $207.5B $100M 0.0% -46.6% BLSH
Q2 '26 $130.6B $140M -0.0% -25.7% BLSH

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BLSH BREAKDOWN
39d in phase · OBV NEUTRAL
Current IV 120.2%
IV Percentile 15th %ile
Put/Call OI Skew 0.71x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact BLSH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AMBQ BREAKDOWN
104d in phase · OBV NEUTRAL
Current IV 96.5%
IV Percentile 27th %ile
Put/Call OI Skew 2.14x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact AMBQ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BLSH Moat Profile Cyclical / Execution-Driven Positioning
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $3.5B market capitalization and -264.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
AMBQ Moat Profile Cyclical / Execution-Driven Positioning
Semiconductors Operator
Competes within the Semiconductors value chain with $1.2B market capitalization and -36.0% operating margin.
OpEx & R&D Reinvestment 80.8% of Rev ($95M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (15 partners):
Taiwan Semiconductor Manufacturing Company ARM Holdings Synopsys Cadence Design Systems

Investor FAQ BLSH vs AMBQ Key Questions & Quantitative Answers

As of Nov 16, 2026, Bullish (BLSH) is the stronger overall head-to-head candidate over Ambiq Micro, Inc. (AMBQ) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). BLSH carries a Unified Composite Score of 51.9/100 (HOLD) at $20.22 (34.1x Forward P/E, -264.8% operating margin), whereas AMBQ carries 46.9/100 (HOLD) at $44.59 (N/M Forward P/E, -36.0% operating margin). Growth vs. Quality Trade-Off: BLSH earns the overall head-to-head edge with a stronger Unified Composite Score (51.9/100 HOLD vs. AMBQ 46.9/100 HOLD) and 2.89β · 91% Vol risk profile, whereas AMBQ leads top-line expansion (+110.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: BLSH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 32.0); meanwhile AMBQ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 42.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BLSH leads the Growth & Scale pillar: BLSH posts +68.8% YoY revenue growth and +0.0% YoY earnings growth on $301M TTM revenue (100.0% gross margin, -264.8% operating margin), compared with AMBQ at +110.0% YoY revenue growth and +0.0% YoY earnings growth on $118M TTM revenue (44.8% gross margin, -36.0% operating margin). Across the 4-period historical trajectory (Q3 '25 to Q2 '26), BLSH cumulative revenue shifted -21.6% while AMBQ shifted +100.0%. In operating R&D and SG&A reinvestment, BLSH deploys N/A (0 90-day corporate R&D disclosures) versus 80.8% of Rev ($95M) (0 disclosures) for AMBQ.

BLSH screens cheaper on headline valuation multiples. BLSH trades at 34.1x Forward P/E, 34.1x Trailing P/E, N/M PEG, and 13.1x EV/Revenue (37.0% FCF margin), whereas AMBQ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 7.3x EV/Revenue (-33.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BLSH (-57.1% ROE) versus AMBQ (-12.2% ROE) capital efficiency.

In options market volatility and institutional positioning, BLSH carries 120.2% implied volatility (15th %ile, Compressed (<25th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (2.89β · 91% Vol realized risk). By comparison, AMBQ carries 96.5% implied volatility (27th %ile, Balanced (25th–60th %ile)), a 2.14x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.71β · 125% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.